• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Roche set to re-join the ABPI

Roche set to re-join the ABPI

September 7, 2016
CenterWatch Staff

The Association of the British Pharmaceutical Industry (ABPI) and Roche have announced that Roche has re-joined the U.K. trade association as a full member.

Mike Thompson, ABPI CEO said, "This is an exciting and critical time for the U.K. pharmaceutical industry as we face up to a number of challenges, in particular addressing life outside of the European Union. It's important that the ABPI can provide a coherent and aligned voice for our industry which represents the views of companies large and small. Therefore, having the world's largest biotech company sign up to full membership really is a boost and couldn't have come at a more crucial time. We very much look forward to working with all of the staff at Roche."

Richard Erwin, general manager, Roche Products said, "Our industry can be subject to significant environmental shifts and we recognise how important it will be to collaborate with other companies, the NHS and healthcare professionals to ensure that U.K. patients can get access to world leading healthcare."  

Roche's U.K. Pharmaceutical business plays a significant role in driving medical advancement, with around 600 employees supporting global and local clinical trials. Globally, it is the world's largest biotech company. It has one of the strongest medicine development pipelines in the industry in healthcare, investing around £6.6 billion in research and development globally every year across oncology, immunology, infectious diseases and neuroscience. 

The decision by Roche to re-join the ABPI is significant, with the trade association now representing nine out of 10 of the world's largest pharmaceutical companies.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing